← Back to Search

Experimental for Body Dysmorphic Disorder

N/A
Recruiting
Research Sponsored by York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-intervention at 8 weeks following baseline
Awards & highlights

Study Summary

This trial compares two online treatments for Body Dysmorphic Disorder; one with mindfulness meditation and one without. Both aim to reduce symptoms and distress.

Eligible Conditions
  • Body Dysmorphic Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-intervention at 8 weeks following baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-intervention at 8 weeks following baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Dysmorphic Disorder Symptom Scale
Secondary outcome measures
Patient Health Questionnaire - 9
Other outcome measures
Brief Pain Inventory
General Anxiety Disorder - 7

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
Online cognitive behavioural therapy with the added components of mindfulness meditation
Group II: Active comparatorActive Control1 Intervention
Online cognitive behavioural therapy alone

Find a Location

Who is running the clinical trial?

York UniversityLead Sponsor
59 Previous Clinical Trials
18,073 Total Patients Enrolled

Media Library

CBT + Mindfulness & EMDR Clinical Trial Eligibility Overview. Trial Name: NCT05402475 — N/A
Body Dysmorphic Disorder Research Study Groups: Experimental, Active comparator
Body Dysmorphic Disorder Clinical Trial 2023: CBT + Mindfulness & EMDR Highlights & Side Effects. Trial Name: NCT05402475 — N/A
CBT + Mindfulness & EMDR 2023 Treatment Timeline for Medical Study. Trial Name: NCT05402475 — N/A
~15 spots leftby Jun 2025